Try our Advanced Search for more refined results
Life Sciences - July, 2023
330 articles
- Bristol-Myers, AstraZeneca Agree To End Drug Patent Fight
- Dog Food Labeling Suit Sent Back To Mo. State Court
- NY Judge Won't Lift Asset Freezes In Gilead Counterfeit Suit
- Shkreli-Tied Pharma Co. Clinches $650K Stalking Horse Bid
- DEA 'Set A Trap' For Opioid Sellers, AmerisourceBergen Says
- Green Groups Press EPA To List New Toxic Pollutants
- Mass. Biotech Co. Hit With Stock Drop Suit Over New Drug
- Ala. AG Hit With Suit Over Out-Of-State Abortion Help
- GAO Raps Biz For Waiting On Calls To Launch Protest
- The Children's Place Sued Over PFAS In School Uniforms
- Abortion Rights Referendum Challenged In Ohio's High Court
- 11th Circ. Ruling May Impede Insurers' Defense Cost Recoup
- Indivior Ruling May Affect Rebate Wall Litigation
- Anesthesiologist Cleared Over Instagram Surgery Video
- Catching Up With Delaware's Chancery Court
- Natera Says Rival Infringes Cancer Testing Patents
- 4 Firms Guide €1B Sale Of Controlling Stake In MedTech Biz
- Labcorp Can't Beat Retirement Plan Mismanagement Suit
- Dinsmore & Shohl Adds Three-Atty Employment Team In LA
- The Compliance Chiefs Who've Faced Legal Hot Water In '23
- Syneos Health Covered Up COVID-19 Turmoil, Investor Says
- Sequenom Beats Suit Over $371M Sale To LabCorp, For Now
- HIV Patients Can Amend Disability Bias Suit Against CVS
- Tivity Appeals Nutrisystem Merger Investor Class Cert, Again
- US Trustee Asks Supreme Court To Pause Purdue Ch. 11 Plan
- FDA Warns Distributors Over Popular, Unauthorized E-Cigs
- Pharma Group Sues Over La.'s Revisions To Drug Pricing
- Don't Miss It: Kirkland, Simpson Thacher Lead Week's Deals
- J&J Again Fails To Get Talc Claims Handled In Bankruptcy
- Atty Fees Sought For $108M Cooley Malpractice Suit In NJ
- UK Litigation Roundup: Here's What You Missed In London
- Cravath, Vinson & Elkins Steer Biogen's $7.3B Reata Buy
- Trending At The PTAB: Claim Substitution And APA Control
- Dignity Is Immaterial In Instagram Surgery Row, Jury Hears
- Allergan Asks 2nd Circ. To End Investors' Breast Implant Suit
- 5 AGs Urge JPML To Group Gov't Insulin Pricing Suits
- DEA Runs Internal Proceedings In A 'Star Chamber,' Atty Says
- Boston Scientific Says Stock Buys DQ Hopeful Lead Plaintiff
- PTAB Cuts Bone Fusion IP From Del. Suit Against Zimmer
- Aetna Can't Decertify ERISA Class Using 9th Circ. Ruling
- GOP Lawmaker Blasts FDA For Inaction On Regulating CBD
- 2 Medical Businesses End $158M IP War Over Surgical Clips
- 6th Circ. Tosses Suit Over Live Woman Brought To Embalmer
- Regenerative Med Cos. To Merge For $65M
- Mylan's Litigation Costs Are Tax Deductible, 3rd Circ. Rules
- Mallory Gives Plaintiffs A Better Shot At Justice
- FTC Cuts Deal Ending Surescripts Monopoly Case
- Ex-Aegerion Rep Says Top Court Ruling Dooms ID Theft Case
- Fitness Trainer's Disability Bias Suit Gets Green Light For Trial
- 22 States Fight 3M's $12.5B 'Forever Chemicals' Settlement
- Fearing $10B FCA Loss, Teva Seizes On Kickback Circ. Split
- Patient Says Instagram Video Caused Emotional Distress
- Cancer Group Targets 'Wrong' HHS Prescribing Limits
- 3 Takeaways From Biden's Mental Health Parity Proposal
- Why Justices' SuperValu Ruling Wasn't Quite A 'Seismic Shift'
- Expect More Mental Health Parity Guidance, DOL Official Says
- Novartis Direct Buyers' Attys Get $42M In Drug Delay Case
- White House Tells 5th Circ. Social Media Order Unprecedented
- Michigan Atty Charged With Smuggling Drugs Into Prison
- Cannabis Cos. Must Heed PFAS Risks In Products, Packaging
- These Firms Have The Most Diverse Equity Partnerships
- UK Billionaire Lewis Denies Insider Trading, Gets $300M Bond
- CORRECTED: N.J. Justices Back New Mesh Trial For C.R. Bard
- Saudi Co. Freed From Breach Suit, But Sanctioned
- Director Picks Up PTAB Denial Over Hormone Treatment
- Insurer Owes $91M For Sterigenics Pollution Suits Defense
- Bausch Must Face Suit Alleging Eye-Implant Complications
- On Deck In JPML: Insulin Pricing, Bard Catheters, Southwest
- Eli Lilly Resets Merger Review Clock On $2.4B Deal
- Chancery Approves Amneal Settlement, $1.88M Atty Fee
- 9th Circ. Axes 'Take-Home' COVID Suit, Citing Calif. Justices
- Elanco's Free Dinner Faxes Don't Trigger TCPA, 7th Circ. Rules
- Teva Exits Cancer Drug IP Row With 2031 Generic License
- Providers Look to Block 'Irrational' Parts Of NC Abortion Law
- RFK Jr. Joins States' Suit Over Biden Social Media Issue
- Ex-Client Owes McCarter & English $1M For Bills, Jury Finds
- Scarinci Hollenbeck Hires Real Estate Pro In New Jersey
- Law360's Diversity Snapshot: What You Need To Know
- Rising Star: White & Case's James Hu
- Biden Admin Unveils Proposed Mental Health Parity Regs
- High Court Didn't Shrink Kickback Law's Scope, DOJ Insists
- 11th Circ. Freezes CoolSculpting User's Product Liability Suit
- 3rd Circ. Backs Dismissal Of Heart Medication Warning Claim
- Biotech Co. Can't Defend Fundraising Claims, SEC Says
- Mass. Telemed Cos. Owner To Admit To $44M Medicare Scam
- Fed. Circ. Won't Touch A Del. Ruling On Hypertension Drug
- L'Oreal, Other Cos. Get Review In Georgia Hair Relaxer Case
- Product Liability Regulation & Legislation To Watch At Midyear
- Biden Threatens Veto Of 2024 VA, Ag. Bills Over Funding Caps
- P&G Slams 'Implausible' Detergent Greenwashing Suit
- SEC Says 2nd Stock Fraud Trial For Conn. Atty Isn't Needed
- ICE Can't Pass Off Responsibility Of Man's Death, Son Says
- Library Of Congress Asks DC Circ. To Keep Fair Use Suit Axed
- Judge Temporarily Halts IQVIA Deal At FTC's Behest
- Feds, Insider Trading Suspect Spar Over BigLaw Binder Info
- Insurance Insights From 5th Circ. Blue Bell Coverage Ruling
- Cozen O'Connor Names Canadian Life Sciences Head
- Fruit Co. Says Tribe's CWA Claims Should Be Tossed
- Courts Can Overturn Deficient State Regulations, Too
- Rising Star: Sullivan & Cromwell's Brad King
- The Litigation Jolting Health & Life Sciences In 2023's 2nd Half
- J&J Lands $18M Judgment In Counterfeit Surgical Tools Suit
- 10th Circ. Won't Revive Suit Over Janssen's Levaquin
- FTC Says To Ignore Its Previous Guidance About PBMs
- Lab Exec Targets Insurers For $1B After Beating DOJ Case
- Pot Cos. Try To Move Toxic Chemical Claims To Arbitration
- Judge OKs Deal Ending Pa. 'Your CBD Stores' Lawsuit
- AbbVie Gets Amicus Backing In 2nd Circ. Bystolic Suit
- Panel OKs Bill To Study Developing Drugs Without Patents
- Life Sci Cos. Should Work With FDA To Shape AI Regulation
- AstraZeneca Trims Sex Harassment Retaliation Suit
- Health Hires: Kleinfeld Kaplan, Michael Best, Creyon
- FTC Tries To Cut Amgen, Horizon's Constitutional Challenge
- Blackstone's 5 Biggest Bets As Firm Tops $1T In Assets
- Trustee To Take Over Estate In Molecular Dynamics Ch. 11
- UK Litigation Roundup: Here's What You Missed In London
- Rising Star: Hyman Phelps' James Valentine
- Tales From The Trenches Of Remote Depositions
- Texas Witness Says Abortion Ban Confusion Sowed By Media
- Last Claims Tossed In McKinsey Opioid Marketing MDL
- 3rd Circ. Backs Axing Pharma Execs' Conspiracy Charge
- Ex-Med. Device Co. Worker Cops To Faking FDA Clearances
- Employer Groups, Insurers Fight For 'No Surprises' Law
- UK Drug Co. Settles For $19.6M Over False Safety Claims
- Shkreli Not Aided By Top Court's 'True Threat' Case, AGs Say
- Illinois Cases To Watch In 2023: A Midyear Report
- Costco Accused Of Destroying Evidence In Contact Lens Suit
- A Practical Solution To Life Sciences Joint Venture Disputes
- Endo International Wins More Support For $6B Ch. 11 Sale
- Deals Rumor Mill: Ramsay Sime Darby, THL, Roivant
- 2023 Is Far From Done With Government Merger Cases
- Rising Star: WilmerHale's Timothy Cook
- Endo Pitches Deal With Distributors Over Ch. 11 Sale Plan
- Texas Abortion Ban Has 'No Mercy' For Suffering, Judge Told
- MetLife Beats ERISA Suit Alleging It Withheld Drug Rebates
- FTC Judge Calls Simultaneous In-House, Fed Cases 'A Waste'
- Pension Fund Says It Lost $33.6M Over Pharma Co.'s Actions
- Pfizer Settles Conn. Trade Secrets Case Against Ex-Execs
- 5 Patent Cases To Watch In The Second Half Of 2023
- Sorrento Asks For Stay Of Employment Suit Against CEO
- Flint Engineering Firm Must Turn Over Media Strategy Docs
- Juul Says It's Seeking FDA OK For New E-Cig Device
- How Life Sciences And Education Industries Can Partner Up
- Employer Drug-Testing Policies Must Evolve With State Law
- Crowell Urges Delay In Walgreens-Humana Conflict Ruling
- TPG To Pay $1.4B For Nextech As Part Of Health Care IT Push
- Biggest Illinois Decisions Of 2023: A Midyear Report
- Tide May Be Turning On Texas Two-Step Bankruptcy Strategy
- Rising Star: Ropes & Gray's Suni Sreepada
- Calif. Justices Open Door To Nonprofits, Unions Suing Cos.
- Danaher Played Down Post-COVID Slump Risk, Investor Says
- GreenLight Shareholders Sue In Del. For Company Books
- J&J Unit Launches 6th Challenge To Drug Price Negotiations
- J&J Owes $19M To Cancer Patient In Calif. Talc Trial
- SEC Fines Ex-Merck Regulatory VP For Insider Trading
- Troutman Pepper Adds New Cannabis Partner In NC
- Iowa Judge Halts 6-Week Abortion Ban Amid Challenge
- NY Towns Object To 3M's $12.5B 'Forever Chemicals' Deal
- Pa. Judge Affirms Nixing Of Expert Testimony Over Autism
- Eli Lilly Worker Urges Class Certification In Age Bias Suit
- 7 Trials To Watch In The Second Half Of 2023
- Talc Claimants' Rep. Slams 'Outrageous Antics' In DQ Bid
- CBD Co. Wants Counterclaims Nixed In Epidiolex Patent Row
- DC Sues 3M, DuPont, Others Over 'Forever Chemicals'
- Lewis Brisbois Adds Gov't Affairs Partner, Ex-Sidley Leader
- Judge Nixes Damages From $45M Natera False Ad Verdict
- Erika Jayne Meets Face-To-Face With Girardi's Alleged Victims
- Pennsylvania Cases To Watch In 2023: A Midyear Report
- Damages Ruling Ups Stakes In FCA Kickback Case Against Teva
- FTC Moves To Block IQVIA Deal Over Health Ad Concerns
- Astellas Says Drug Price Negotiation Law Is 'Unconstitutional'
- The Biggest Patent Rulings Of 2023: A Midyear Report
- FTC Seeks Pause Of $28B Amgen Deal Amid Challenge
- 1st Trial Down In Abbott's Patent War In Delaware
- Blunders That Made 'Bakked' Cannabis TM Go Up In Smoke
- $255M Juul Deal Doesn't Address Addiction, Objectors Say
- Texas Atty Convicted For Role In Medical Kickback Scheme
- Westlake Village BioPartners Launches $450M Fund
- Justices Quietly Added Ammo To Big Pharma's Kickback Blitz
- McKesson Investor Attys Get $35M For $141M Price Fix Deal
- 5th Circ. Pauses Limits On Biden Admin Social Media Collabs
- PTAB Can't Interfere With AIA Patents, Fed. Circ. Says
- DEA Must Produce Data For Opioid MDL Trials, Judge Rules
- Sorrento DIP Lender Opposes Short-Selling Settlement
- Electronic Health Records Co. To Pay $31M To End DOJ Suit
- Opioid Distributor Takes Cherokee Case To Federal Court
- Nerve Stimulator Co. Again Beats Investor Suit Over $78M IPO
- Challenging Standing In Antitrust Class Actions: Timing
- Trustee Wants Out Of Suit Over Radiology Co.'s ESOP
- Health Hires: Venable, McDermott, Arbutus
- Strategies For Patent Drafting As Eligibility Questions Linger
- 3 Firms Steer Upsized Biotech IPOs Raising $385M Combined
- Level Up Lawyers' Business Development With Gamification
- UK Litigation Roundup: Here's What You Missed In London
- Eli Lilly Buying Obesity Drugmaker Versanis In Near-$2B Deal
- Republican AGs Warn CEOs About Bias After Harvard Ruling
- 'Ridiculous': Texas Judge Unloads On Biden's Abortion 'Fiats'
- AIA Challenges To Drug Patents Are Down, USPTO Finds
- Gov't Takes 'No Surprises Act' Challenge To 5th Circ.
- Court Won't Cut Pre-2009 Smith & Nephew Hip Implant Claims
- FTC Nears Deal To End Surescripts Monopoly Case
- 11th Circ. Says Insurers Can't Recoup Drug Co.'s Suit Costs
- Baxter Hid Supply Chain Woes From Shareholders, Suit Says
- Mich. Blasts $5M Fee Ask In Flint Water Case As 'Overreach'
- 2nd Circ. Revives Niagara Falls Radioactive Waste Claims
- Holmes, Kapoor Aided By Push To Curb Prison Time
- Addressing Legal Issues Raised By AI Use In Health Care
- Mallory Ruling Leaves Personal Jurisdiction Deeply Unsettled
- Vancouver Man Extradited To Face Stock Fraud Charges
- Talc Claimants' Rep. Faces DQ Bid Over Dinner With J&J Atty
- DEA Wrongly Refuses To Reconsider Psilocybin, 9th Circ. Told
- Boston Scientific Pelvic Mesh Case Settled Ahead Of Trial
- Shkreli Argues 'True Threat' Case Backs Lifting Pharma Ban
- FDA Clears Over-The-Counter Birth Control Pill
- 3M Calls Bid To Disqualify MDL Judge 'Gamesmanship'
- 2nd Circ. Cites Misjudged Impact Of Deficient Immigration Atty
- AmerisourceBergen Investors Pan Drug-Dregs Suit Report
- Texas DAs' Abortion Silence Bars Outsiders' Help, Groups Say
- IP Toolbox Is Crucial In AI-Powered Drug Discovery
- Court Tosses AstraZeneca's Challenge To USPTO's Fintiv Rule
- Worker Says LifePoint's Bid To Duck Wage Suit Is Premature
- Singapore's Quadria Selling FV Hospital Stake For $381M
- 5 Ways Firms Can Rethink Office Design In A Hybrid World
- Illumina Fined €432M For Closing Grail Deal Without EU OK
- Holmes Free In 2032? Agency Projects Release 2 Years Early
- Client Hailed McCarter & English Before Malpractice Claim
- Merck Cites 'Gulag,' Jeers HHS 'Backtracking' As Suits Surge
- Travelers Units Beat Blue Bell Coverage Suit At 5th Circ.
- Mich. Panel Skeptical State Can Salvage PFAS Rules
- Judge Calls Drugmaker's Bid To Strike 'A Bit Disingenuous'
- Ag. Board Says Union Isn't Bona Fide Org. Under Calif. Law
- Express Scripts Fights Acthar Antitrust Class Cert. Bid
- 11th Circ. Won't Revive Pension Fund's Suit Against MiMedx
- A Midyear Look At How AI Is Affecting Lawyers
- CSX Shouldn't Escape Asbestos Claims, Widow Says
- NJ Town Illegally Barred Pot Cos. Development, Suit Says
- Philips Says CPAP MDL Shows No Exposure To Foam Toxins
- Wilson Sonsini Hires Former Biotech GC As Client Adviser
- Psychedelics Litigation To Watch In 2nd Half Of 2023
- Bar Score Is Best Hiring Metric Post-Affirmative Action
- Same Judge To Hear Atty's 2nd Trial After Jury Poll Gaffe
- Defense Counsel Sentencing Lessons From Holmes Case
- Biden Admin Can't Pause Social Media Order During Appeal
- J&J Could Have Saved Talc User In '90s, Jury Hears
- Abbott, Mead Get Tentative Win In Suit Over Infant Formula
- Full 11th Circ. Sends Ga. Doc's Roundup Case Back To Panel
- Mallinckrodt Hit With Investor Suit After Mulling 2nd Ch. 11
- Colo. Biotech Buyout Spawns Stock Fight With Researcher
- Alexion Trial Starts Over Ditched Drug Worth 'Billions'
- McCarter & English Client Didn't Notice Rate Hikes, Jury Hears
- Ex-Pot Co. Worker Says COVID Masking Suit Must Proceed
- Ex-Choate Patent Pro Makes Move To Dechert
- Philips Cites Federal Preemption To Sink CPAP MDL Claims
- USPTO Efforts On Patent Bar DEI Miss Underlying Issues
- FDA Trends Show Compliance Priorities For Supplement Cos.
- Bayer Hits Supplier With $12M Benzene Contamination Suit
- AI-Based Pharma Co. Faces Investor Suit Over Study Woes
- Robbins Geller To Lead Amgen Investors In $10B Tax Bill Suit
- Fed. Circ. Probes Predictability Of Hair Loss Treatment Patent
- Catching Up With Delaware's Chancery Court
- Medtronic Wants Fed. Circ. To Rethink Catheter IP Decisions
- Former Gilead GC Rejoins Gunderson Dettmer In Calif.
- Fed. Circ. Says PTAB Ruling Was 'Infected By Error'
- Israel's Oddity Tech Leads 3 IPOs That Could Net $625M Total
- Zurich Unit Says $3.7M Lab Fire Suit Must Go To Trial
- Conn. Atty Says SEC 'Detached From Reality' In Judge Spat
- DOJ Lambastes Idea Of '3-Part Test' In High Court FCA Ruling
- HHS Floats $9B Drug-Discount Fix After High Court Loss
- Split PTAB Invalidates Some Leukemia Drug Patent Claims
- Ruling Conflicts With 'Day'-Old Fed. Circ. Precedent, Biz Says
- DaVita Nurses Win Partial Cert. In Meal Breaks Suit
- Delaware Judge Axes Novartis Patent On Heart Failure Drug
- Nurse Says Hospital's Bid To Shake Wage Suit Is Delay Tactic
- Pot Co. Manager Says Owner's Cross Claims Must Be Tossed
- LTL Again Takes Aim At Doctors Linking Talc To Mesothelioma
- Venture-Backed Startups Cinch Belts To Survive Lean Times
- 9th Circ. Won't Undo FDA's Denial Of Vape Applications
- Novo Nordisk Hits Pharmacies With Suits Over Ozempic
- Del. Chancery Calls For Progress In NuVasive-Alphatec Suit
- Engineering Co. Reaches Tentative Deal On Flint Water Claims
- Montgomery McCracken Attys Sued For Abuse Of Process
- DOJ's Merger Record Improves & Other Early 2023 Highlights
- Ghosting In BigLaw: How To Come Back From Lack Of Feedback
- UK Litigation Roundup: Here's What You Missed In London
- Novartis Wins Judgment In Mylan Heart Drug Patent Fight
- FDA Alzheimer's Drug OK Opens Door To Medicare Coverage
- IP Pro Returns To Kasowitz After Brief Greenberg Traurig Stint
- Philly Children's Hospital Wants End To COVID Vax Bias Suit
- Pharma Cos. Urge High Court To Toss Terror-Funding Ruling
- Bausch & Lomb Pays $106M For J&J Eye Drop Line
- Mitigating Risks Of Developing Drugs And Devices With AI
- Thermo Fisher Pays $912M For Ropes-Led Health Data Co.
- Attys Seek $2M For Pharma Biz Suit Settlement In Del.
- Mass. Justices Affirm Time Limit On Smoking Death Claims
- Cooley Life Sciences Pro Jumps To Arnold & Porter In LA
- Paul Hastings Hires 2 Ex-Goodwin Attys To Head Practices
- FCA Defense Bar Tries Flipping Script On High Court Ruling
- 9th Circ. Revives Ariz. Co.'s IP Fight With NY Amazon Resellers
- SEC Fines COVID Test Maker, Execs Over Disclosures
- Generic-Drug Makers Challenge Minn. Price Control Law
- FTC Drops Case Over Altria's Unwound Juul Investment
- How A 3-Firm 'Joint Effort' Beat A $3.6B Pharma Antitrust Suit
- Fed. Circ. Revives Bovine Sperm Sorting Patent Feud
- Sorrento Therapeutics Cleared For New $20M Loan In Ch. 11
- FDA And FTC Crack Down On THC 'Copycat' Snacks
- Flint Class Says Engineers Owed Duty To Them, Not Just City
- Product Liability Cases To Watch: 2023 Midyear Report
- Steps To Success For Senior Associates
- Feds Drop Appeal In Suit Over Trans Care Policy
- DuPont Poisoned Cape Fear River With PFAS, Suit Says
- Can M&A Bounce Back After Dismal First Half Of 2023?
- Abbott Reups Glucose Monitor Patent Spat With Dexcom
- Waymaker Found Path To Penile IP Win Via Defendant Exam
- FTC Wades Into Medtronic Surgical Device Antitrust Spat
- Brita IP Win Dampened By Commission Review
- Humira Rivals Finally Flood Market After 'Patent Thicket' Saga
- 3 Takeaways From The Supreme Court's Session
- Sun Infringes Orexo's Opioid Addiction Drug IP, Judge Rules
- Law360 Podcasts Untangle A Week Of Blockbuster Rulings
- Paul Hastings Accused Of Causing 'Demise' Of GenapSys
- The Sharpest Dissents From The Supreme Court Term
- The Funniest Moments Of The Supreme Court Term
- Jackson Debuts As Chattiest Justice
- Judge Cites 'Patent Misuse' In Ending Bard's $52M Lawsuit
- Sorrento Therapeutics Seeks New $20M DIP Loan
- Legal Profession Must Do More For Lawyers With Disabilities
- Breaking Down The Vote: The High Court Term In Review
- The Firms That Won Big At The Supreme Court
- Tax Claim Shows Injury In Pharmacy Breach, 1st Circ. Says
- Trending At The PTAB: Disclaiming A Design Claim